Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults

Clinical Infectious Diseases

Volumn 60, Issue 4, 2015, Pages 627-638

  Althoff, Keri N ^a   McGinnis, Kathleen A ^b   Wyatt, Christina M ^c   Freiberg, Matthew S ^d   Gilbert, Cynthia ^e   Oursler, Krisann K ^b,f   Rimland, David ^g   Rodriguez Barradas, Maria C ^h   Dubrow, Robert ⁱ   Park, Lesley S ⁱ   Skanderson, Melissa ⁱ   Shiels, Meredith S ^j   Gange, Stephen J ^a   Gebo, Kelly A ^a   Justice, Amy C ⁱ  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j NATIONAL CANCER INSTITUTE   (United States)

more..

Author keywords

aging; end stage renal disease; HIV infection; myocardial infarction; non AIDS defining cancers

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGING; COHORT ANALYSIS; COMPARATIVE STUDY; COMPLICATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASMS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK; STATISTICAL MODEL; VETERAN; YOUNG ADULT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGING; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; VETERANS; YOUNG ADULT;

EID: 84922387803     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu869     Document Type: Article

References (38)

1. May MT, Ingle SM. Life expectancy of HIV-positive adults: a review. Sexual Health 2011; 8:526-33.
2. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
3. Samji H, Cescon A, Hogg RS, et al. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8:e81355.
4. The HIV and Aging Consensus Project. Recommended treatment strategies for clinicians managing older patients with HIV. American Academy of HIV Medicine. Available at: http://aahivm.org/Upload- Module/upload/HIV%20and%20Aging/Aging%20report%20working% 20document%20FINAL%2012.1.pdf. Accessed 20 October 2014.
5. Martin J, Volberding P. HIV and premature aging: a field still in its infancy. Ann Intern Med 2010; 153:477-9.
6. Pathai S, Bajillan H, Landay AL, High KP. Is HIV a model of accelerated or accentuated aging?. J Gerontol A Biol Sci Med Sci 2014; 69: 833-42.
7. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care 2006; 44(8 suppl 2):S25-30.
8. Every NR, Fihn SD, Sales AE, Keane A, Ritchie JR. Quality Enhancement Research Initiative in ischemic heart disease: a quality initiative from the Department of Veterans Affairs. Med Care 2000; 38(6 suppl 1):I49-59.
9. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123:187-94.
10. Engels EA, Brock MV, Chen J, Hooker CM, Gillison M, Moore RD. Elevated incidence of lung cancer among HIV-infected individuals. J Clin Oncol 2006; 24:1383-8.
11. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med 2008; 148:728-36.
12. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-Analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52:611-22.
13. Silverberg MJ, Chao C, Leyden WA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS 2009; 23:2337-45.
14. McGinnis KA, Brandt CA, Skanderson M, et al. Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res 2011; 13:1233-9.
15. Kraemer KL, McGinnis KA, Skanderson M, et al. Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care 2006; 44(8 suppl 2): S44-51.
16. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS 2005; 19(suppl 3):S99-105.
17. Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC. Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection. Hepatology 2004; 40:115-9.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-70.
19. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-52.
20. Deeks SG, Lewin SR, Havlir DV. The end of AIDS: HIV infection as a chronic disease. Lancet 2013; 382:1525-33.
21. Justice AC, Braithwaite RS. Lessons learned from the first wave of aging with HIV. AIDS 2012; 26 (suppl 1):S11-8.
22. High KP, Brennan-Ing M, Clifford DB, et al. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr 2012; 60 (suppl 1):S1-18.
23. Silverberg MJ, Chao C, Leyden WA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev 2011; 20:2551-9.
24. Lucas GM, Mehta SH, Atta MG, et al. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS 2007; 21:2435-43.
25. Silverberg MJ, Leyden WA, Xu L, et al. Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care. J Acquir Immune Defic Syndr 2014; 65:160-6.
26. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92:2506-12.
27. Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013; 173: 614-22.
28. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav 2010; 14:824-35.
29. Kaplan RC, Kingsley LA, Sharrett AR, et al. Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis 2007; 45:1074-81.
30. Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients-Association with antiretroviral therapy. Results from the DAD study. AIDS 2003; 17:1179-93.
31. Beachler DC, Weber KM, Margolick JB, et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and atrisk HIV-negative adults. Cancer Epidemiol Biomarkers Prev 2012; 21:122-33.
32. van Baarle D, Hovenkamp E, Dukers NHTM, et al. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J Infect Dis 2000; 181:2045-9.
33. Thio CL. Hepatitis B and human immunodeficiency virus coinfection. Hepatology 2009; 49(5 suppl):S138-45.
34. Centers for Disease Control and Prevention. HIV surveillance report, 2012. Vol. 24. Available at: http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2014. Accessed 11 November 2014.
35. Sigel K, Dubrow R, Silverberg M, Crothers K, Braithwaite RS, Justice AC. Cancer screening in patients infected with HIV. Curr HIV AIDS Rep 2011; 8:142-52.
36. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?. Clin Infect Dis 2007; 45:1593-601.
37. Onen NF, Overton ET. A review of premature frailty in HIV-infected persons; another manifestation of HIV-related accelerated aging. Curr Aging Sci 2011; 4:33-41.
38. Edelman EJ, Gordon KS, Glover J, McNicholl IR, Fiellin DA, Justice AC. The next therapeutic challenge in HIV: polypharmacy. Drugs Aging 2013; 30:613-28.